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Despite the increasing use of non-invasive ventilation and high-flow nasal-oxygen therapy, intubation is still
performed in a large proportion of critically ill patients. The aim of this narrative review is to discuss recent data on
long-term intubation-related complications, such as microaspiration, and tracheal ischemic lesions. These complications
are common in critically ill patients, and are associated with substantial morbidity and mortality. Recent data suggest
beneficial effects of tapered cuffed tracheal tubes in reducing aspiration. However, clinical data are needed in critically
ill patients to confirm this hypothesis. Polyurethane-cuffed tracheal tubes and continuous control of cuff pressure could
be beneficial in preventing microaspiration and ventilator-associated pneumonia (VAP). However, large multicenter
studies are needed before recommending their routine use. Cuff pressure should be maintained between 20 and 30
cmH2O to prevent intubation-related complications. Tracheal ischemia could be prevented by manual or continuous
control of cuff pressure.
Keywords: Intubation; Complications; Microaspiration; Ventilator-associated pneumonia; Tracheal ischemiaIntroduction
Nowadays, tracheal intubation is less performed in the ICU
because of the increasing use of non-invasive ventilation
and high-flow nasal-oxygen therapy [1-4]. However, this in-
vasive procedure is still performed in a high percentage of
critically ill patients requiring mechanical ventilation. A
large multicenter epidemiological study was performed in
927 ICUs, and included 18,302 patients requiring mechan-
ical ventilation for > 12 hours [5]. The percentage of pa-
tients requiring invasive mechanical ventilation through a
tracheal tube decreased from 95% in 1998 to 86% in 2010.
However, 30% of patients who received non-invasive venti-
lation required subsequent intubation.
In this narrative review, we will report and discuss
data on long-term intubation-related complications. We
will also review the impact of shape, volume, and mater-
ial of the tracheal cuff on the incidence of these compli-
cations. Finally, we will discuss data on the optimal care
for the tracheal cuff.* Correspondence: s-nseir@chru-lille.fr
1Pôle de Réanimation, Hôpital Salengro, CHRU de Lille, Université Nord de
France, Lille, France
2Critical Care Center, Corporacion Sanitaria Universitaria Parc Tauli, Sabadell
University Hospital, Universidad Autonoma de Barcelona, CIBER Enfemedades
Respiratorias, Sabadell, Spain
© 2014 Jaillette et al.; licensee Springer. This is
Attribution License (http://creativecommons.or
in any medium, provided the original work is pData for this review were identified through searches
of PubMed, and from bibliographies of relevant articles.
We performed a comprehensive search in PubMed, from
1983, through 2013, using the terms “tracheal cuff AND
microaspiration”, “tracheal cuff AND pneumonia”, “tra-
cheal cuff AND ischemia”, “tracheal cuff AND complica-
tions”. The search was limited to publications in English
and French.
Review
Complications related to the tracheal cuff
Complications related to intubation could be classified
into immediate and long-term complications. Microas-
piration and tracheal ischemia are common long-term
complications in the critically ill patient.
Microaspiration
Microaspiration of contaminated oropharyngeal and gastric
secretions is the major route of entry for bacteria into the
lower respiratory tract [6]. Tracheobronchial colonization
might progress to ventilator associated tracheobronchitis
and pneumonia when local and general host defenses are
altered, and when the quantity and virulence of bacteria are
high [7]. Microaspiration occurs in up to 88% of intubated
critically ill patients [8]. Several factors are implicated in thean Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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mechanical ventilation, enteral nutrition, and patient-related
factors [6] (Figure 1). Therefore, prevention of microas-
piration and ventilator-associated pneumonia (VAP) is a
multifactorial process that should take into account all of
these factors [9].
The tracheal tube prevents closure of vocal cords, and
represents an access for bacteria to progress in the trachea
through the folds of high-volume low-pressure tracheal
tubes into the lower respiratory tract [7]. Underinflation of
the tracheal cuff under 20 cmH2O results in microaspira-
tion, and was identified as an independent risk factor for
VAP [10]. However, this cut-off is based on one single cen-
ter study including few patients. Therefore, microaspira-
tion could probably occur at highest or lowest levels of
cuff pressure. Mechanical ventilation plays an important
role in microaspiration, and cuff pressure is tightly corre-
lated with airway pressure [11]. The application of a posi-
tive end expiratory pressure was identified as protective
from microaspiration and VAP [12,13]. Tracheal suction-
ing could be associated with higher risk for microaspira-
tion, because of negative pressure applied during this
procedure. It has been demonstrated that leakage rate
around the cuff depends on the difference in pressure be-
tween the two areas above and below the cuff [14]. A re-
cent study was conducted in 25 intubated critically ill
patients to determine the impact of tracheal suctioning on
leakage of blue dye, diagnosed using fiberoptic bronchos-
copy [15]. Whilst blue dye was observed in the folds
within the cuff wall in a larger number of patients beforeRisks factors related to 
mechanical ventilation
- Zero positive end 
expiratory pressure




- Pressure above the cuff
- Viscosity of secretions above the
cuff
- Tracheal diameter




Figure 1 Risk factors for microaspiration in the critically ill patient.compared with after suctioning, the difference did not
reach statistical significance (P = 0.063).
Enteral nutrition through a nasogastric tube is a recog-
nized risk factor for microaspiration and VAP mainly be-
cause of gastroesophageal reflux [16]. Gastric distension,
loss of anatomical integrity of the lower esophageal sphinc-
ter, increased frequency of transient sphincter relaxation
and oropharyngeal dysphagia via desensitization of the
pharyngoglottal adduction reflex are the main mechanisms
explaining the role of enteral nutrition in aspiration [17].
Patient-related factors could be classified into local and
general factors. Viscosity of secretions above the cuff and
tracheal diameter are the main local factors influencing
microaspiration [14]. Sedation, coma, supine position, and
hyperglycemia are general patient-related factors also influ-
encing microaspiration [18]. Sedation and coma are well
known risk factors for microaspiration and VAP. Degluti-
tion alteration, impairment in tubular esophageal motility
and increased gastrointestinal reflux disease might explain
this relationship [19]. Supine position was identified as a
major risk factor for aspiration and VAP in studies using
technetium 99 m [20]. Further, hyperglycemia increases the
risk for microaspiration by delayed gastric emptying.
Whilst microaspiration is common in intubated critic-
ally ill patients, its diagnosis remains challenging. The gold
standard for diagnosing microaspiration of gastric con-
tents is technetium 99 m [21]. However, this marker is
radioactive, and its use is not allowed in the ICU without
specific precautions. Other markers such as blue dye [15],
bile acids [22], pepsin [23], and amylase [24,25] wereRisk factor related to enteral
nutrition
- Gastrooesophageal reflux
- Loss of anatomical integrity 
of lower oesophageal sphincter
- Gastric distension
Risks factors related to the tracheal
tube
- Impossible closure of vocal cords
- Bacterial biofilm
- Longitudinal folds in HVLP tracheal
cuff
- Underinflation of tracheal cuff
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markers should be taken into account, including low
specificity, qualitative assessment of microaspiration,
short window for their detection in tracheal aspirates,
technical difficulties, and absence of validation com-
pared with the gold standard.
Tracheal ischemia
Few studies have evaluated the incidence of ischemic
tracheal lesions in critically ill patients [26-28]. Based on
their results, the incidence of these lesions varies from
31% to 95% of critically ill patients. The most frequently
described lesions are hyperemia, ischemia, ulcer, granu-
loma, and tracheal rupture. Usually, these lesions are
seen at the zone of contact with the tracheal cuff.
Overinflation of the tracheal cuff (> 30 cmH2O) is the
main risk factor for ischemic tracheal lesions [29]. Simi-
lar as for microaspiration, the cut-off (30 cmH2O) for
ischemic lesions is based on only one study, and these
lesions may well occur at different levels of cuff pres-
sure. Several factors influence cuff pressure, including
quantity of air injected in the cuff [30], the ratio be-
tween cuff and tracheal diameter, cuff physical charac-
teristics [31], patient temperature [32], airway pressure
[11], and patient position [33]. Other risk factors for
tracheal ischemia include hypotension [34], hypoxemia
[27,35], inflammation [36], and subglottic secretion
drainage [37,38] (Figure 2). Seegobin and van Hasselt
[29] performed a prospective study in 40 patients intu-
bated with a high-volume low-pressure cuffed tracheal
tube for surgery under general anesthesia. They evalu-
ated tracheal perfusion at different cuff pressure levels
(from 30 to 100 cmH2O), and found important reduc-
tion in mucosal capillary blood flow above 30 cmH2O,
and a total obstruction above 50 cmH2O. Animal stud-
ies with histological examination confirmed these re-
sults [39]. An animal study demonstrated that tracheal
ischemia was substantially increased by hypotension
[34]. Further, two clinical studies found hypoxemia to
increase the severity of tracheal injury [27,35]. Another
suggested mechanism for tracheal ischemia is inflamma-
tion resulting from the presence of the tracheal tube, and
repeated ischemia-reperfusion [36]. Subglottic secretion
drainage was also reported as a risk factor for tracheal is-
chemia. However, only one animal, and a small clinical
study implicated subglottic secretion drainage in tracheal
ischemic lesions [37,38]. Our group performed a study to
determine risk factors for ischemic tracheal lesions in a
cohort of 96 critically ill patients. These lesions were diag-
nosed using fiberoptic tracheoscopy performed during the
24 hours following extubation [28]. The only independent
risk factor for ischemic tracheal lesions was duration of
assist-control mechanical ventilation through a tracheal
tube. This result could be explained by the fact that airwaypressure is usually higher in assist-control compared with
pressure-control mechanical ventilation, resulting in higher
cuff pressure.
Several complications could occur after severe tracheal
ischemic lesions, such as tracheal stenosis [40], tracheal
rupture [41], tracheobronchiomalacia [42], tracheoinnomi-
nate artery fistula [43], and tracheoesophageal fistula [44].
However, few data are available on the transition from
ischemic tracheal lesions to these complications. In the
above-discussed study [28], we performed a second fiber-
optic tracheoscopy two weeks after the last extubation in
22 patients with severe ischemic lesions. The lesions com-
pletely healed in the majority of patients, suggesting that
when cuff pressure is correctly controlled, even with a
manometer, no complication would occur.
Different types of tracheal cuff
Tracheal tubes can be classified based on the relation-
ship between volume and cuff pressure. Cuff shape and
material can also differ between tracheal tubes.
Pressure-volume relationship
The first tracheal cuffs were small-volume high-pressure.
These cuffs allow sealing with a small area of contact with
tracheal wall, but require high pressure (> 50 cmH2O) to
obtain tracheal sealing. The cuff pressure allowing adequate
sealing is much higher than the perfusion pressure of tra-
cheal mucosa resulting in tracheal injury. Their use was as-
sociated with high incidence of ischemic tracheal lesion and
subsequent complications such as tracheal stenosis and
rupture. These cuffs are unfortunately still available on the
market, and used in some patients, but should be aban-
doned because of the high risk for tracheal injury.
Most currently used cuffs are high-volume low-pressure.
Several in vitro and animal studies showed that these
cuffs require lower pressure to obtain sealing, and were
associated with reduced ischemic tracheal lesions [39,45].
Honeybourne and colleagues [46] performed a random-
ized controlled study in 28 patients requiring intubation
and mechanical ventilation for 24 hours. Patients were ran-
domized to be intubated with a high-volume low-pressure
or a low-volume high-pressure cuff. A fiberoptic bronchos-
copy was performed at the time of extubation to evaluate
ischemic lesions based on a score including edema, inflam-
mation, and ulceration. The authors reported significantly
lower incidence of ischemic tracheal lesions in patients
intubated with high-volume low-pressure cuffed tubes
compared with those intubated with low-volume high-
pressure cuffed tubes. However, several studies have
shown that even when tracheal cuff pressure is adjusted
below 30 cmH2O, ischemic tracheal lesions could still
occur in patients intubated with high-volume low-
pressure cuffs [47,48]. One potential explanation is that
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Figure 2 Risk factors for ischemic tracheal lesions. HPLV, high-volume low-pressure.
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ate in critically ill patients, since these lesions could be
seen at lowest cuff pressure level, especially in patients
with shock or hypoxemia. To obtain optimal sealing with
high-volume low-pressure cuffs, they should be inflated
to obtain a volume above tracheal diameter. As a conse-
quence, channels occur between the polyvinylchloride
(PVC) cuff and tracheal wall, resulting in microaspiration
of contaminated secretions above the cuff into the lower
respiratory tract.
Recently, low-volume low-pressure cuffs have been
studied in critically ill patients. These silicone cuffs
provide accurate sealing of the trachea with acceptable
pressure (< 30 CmH2O). Young and colleagues [49]
evaluated these cuffs in vitro, in patients anesthetized
for surgery, and in critically ill patients. Their results
showed significantly lower leakage using these cuffs
compared with conventional high-volume low pressure
PVC-cuffed tracheal tubes. However, in their clinical
studies two additional measures for prevention of as-
piration were used, namely, continuous control of cuff
pressure and subglottic secretion drainage. Therefore,
it is difficult to determine whether the reduced aspir-
ation rate found in their study was related to the low-
volume low-pressure cuff or to other interventions. A
subsequent retrospective study from the same group
reported zero VAP rate in a cohort of 53 patients, inspite of reintubation of 83% study patients at ICU admis-
sion, suggesting a benefit from these tracheal tubes [50].
Cuff shape
Three cuff shapes are available in barrel (standard), cylin-
drical, and conical (tapered) shape. Unfortunately, few
data are available on the impact of cuff shape on microas-
piration, and VAP. Results of in vitro studies suggest im-
proved sealing using the conical-shaped cuffs [51-53].
This beneficial effect is attributed to the fact that tracheal
diameter is not constant, and that a conical cuff might
provide a sealing zone whatever the tracheal diameter. A
recent randomized study found that short-term use of
taper-shaped PVC cuffs in surgical patients resulted in
more effective sealing of the tracheal lumen in comparison
with traditional barrel-shaped PVC cuffs [54]. However,
further large randomized studies are needed to evaluate
the impact of cuff shape on microaspiration and VAP in
critically ill patients.
Cuff material
Polyurethane could reduce the risk of microaspiration and
VAP. This material is much thinner than PVC, resulting
in reduced formation of folds between the cuff and tra-
cheal wall. Several in vitro studies showed that polyur-
ethane significantly reduced leakage around the tracheal
cuff [51,52]. However, results of clinical studies are
Jaillette et al. Annals of Intensive Care 2014, 4:7 Page 5 of 9
http://www.annalsofintensivecare.com/content/4/1/7controversial. Lucangelo and colleagues [55] performed
a randomized controlled study to evaluate the effect of
polyurethane and a positive end expiratory pressure on
microaspiration of blue dye, diagnosed using fiberoptic
bronchoscopy, in 40 critically ill patients. These combined
measures were found to significantly reduce microaspira-
tion. In a before-after study, performed in 76 consecutive
patients and using pepsin as a marker of microaspiration,
our group also found polyurethane to be associated with
significantly less microaspiration [56]. In contrast, a recent
randomized controlled study using radioactive technetium
m99 to diagnose microaspiration, found no significant dif-
ference in microaspiration between patients intubated
with polyurethane-cuffed compared with those intubated
with PVC-cuffed tracheal tubes [57].
Three clinical studies evaluated the impact of polyureth-
ane on the incidence of hospital acquired pneumonia
[58-60]. All these studies found significantly lower inci-
dence of VAP or nosocomial pneumonia. However, some
limitations of these studies should be taken into account,
including the combined use of subglottic secretion drain-
age [59], before-after design [58], and clinical diagnosis of
pneumonia [58,60].
Regulation of cuff pressure
Based on recent recommendations, cuff pressure should
be checked and adjusted around 25 cmH2O, at least
twice a day using a manometer. Unfortunately, this rec-
ommendation is not followed in a large number of ICUs.
Discontinuous manual regulation
Even when well applied, discontinuous control of cuff
pressure using a manometer is not efficient in keeping cuff
pressure within the recommended range (20 to 30
cmH2O). In a cohort of 101 critically ill patients intubated
with a PVC-cuffed tube, cuff pressure was continuously
recorded for eight hours after manual adjustment of cuff
pressure at 25 cmH2O [61]. Only 18% of study patients
spent 100% of recording time with normal (20 to 30
cmH2O) cuff pressure. Fifty-four per cent of study patients
developed cuff underinflation, 73% developed cuff overin-
flation, and 44% developed both. Thirty-three per cent of
study patients developed underinflation or overinflation
for > 30 minutes. No modifiable risk factor for underinfla-
tion or overinflation of the tracheal cuff was identified in
that study. Duration of intubation and absence of sedation
were independently associated with underinflation of the
tracheal cuff. Percentage of time spent with underinflation
of the tracheal cuff significantly increased during the re-
cording period, suggesting that cuff pressure should be
checked and regulated more frequently using a manom-
eter. However, previous studies showed that the connec-
tion of manometer to external cuff is associated with a
sudden drop in cuff pressure which might result inmicroaspiration [62,63]. In another prospective study, our
group aimed to determine the impact of cuff shape and ma-
terial on cuff pressure [56]. Patients were intubated with
PVC standard (n = 26), polyurethane cylindrical (n = 22), or
polyurethane conical-shaped cuffed (n = 28) tracheal tubes.
Cuff pressure was continuously recoded for 24 hours, and
adjusted by nurses using a manometer thrice a day. Patients
spent 51% to 62% of recording time within the normal
range. No significant difference was found in percentage of
time spent with underinflation, and overinflation between
the three groups. However, coefficient of variation of cuff
pressure was significantly higher in patients intubated with
conical-shaped cuffed tracheal tubes compared with the
two other groups.
Whilst control of cuff pressure using a manometer is not
efficient in keeping cuff pressure within the zone of 20 to
30 cmH2O, this measure is probably better than no control
at all. Several studies have shown that the finger method is
inaccurate in estimating cuff pressure, and that patients
could spend a long period of time with underinflation or
overinflation of cuff pressure when no adjustment is per-
formed at all [30]. Further, a recent randomized controlled
study performed on a large number of patients scheduled
for elective surgery found proper control of cuff pressure
using a manometer to be associated with significantly re-
duced clinical complications such as cough, sore throat,
hoarseness, and blood-streaked expectorant, related to cuff
overinflation compared with no measurement of cuff pres-
sure [64]. However, to our knowledge, no study has evalu-
ated the impact of discontinuous control of cuff pressure
using a manometer on the incidence of complications re-
lated to underinflation or overinflation of tracheal cuff in
ICU patients.
In order to improve the efficiency of manual control of
cuff pressure using a manometer, an alarm could be used
to accelerate nurse intervention, and to reduce time spent
with tracheal cuff underinflation or overinflation. Sole and
colleagues [65] performed a randomized controlled cross-
over study to evaluate the effect of continuous monitoring
of cuff pressure, combined with an alarm, in maintaining
cuff pressure in the target range. Patients (n = 32) received
two 12-hour periods of routine care and continuous moni-
toring of cuff pressure. During the intervention period,
when pressure fell out of the target range of 20 to 30
cmH2O, an alarm warned the nurse, who adjusted cuff
pressure. This intervention allowed reduction of the per-
centage of cuff pressure values out of range (11.1% versus
51.7%, P < 0.001). However, the effect of this intervention
on VAP prevention is unknown. Moreover, this proced-
ure, adding extra work for nurses and an extra alarm in
today’s already noisy and stressful ICU environment for
patients and healthcare workers, could hardly be an ef-
fective solution for maintenance of cuff pressure within
therapeutic range.
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Recently, several devices aiming at continuously control-
ling cuff pressure were studied. Two different types of
devices are available, pneumatic and electronic. The effi-
ciency of the pneumatic device continuously controlling
cuff pressure was demonstrated in two studies per-
formed on critically ill patients and in animals intubated
with PVC-cuffed tracheal tubes [66,67]. These data were
recently confirmed by a randomized study performed by
our group on patients intubated with polyurethane-
cuffed tracheal tubes [68]. Whilst efficiency of electronic
devices was reported by an in vitro study, few clinical data
are available on the efficiency of electronic devices in con-
trolling cuff pressure. In a recent randomized cross-over
study, Brisson and colleagues [69] compared the efficiency
of an electronic device to that of a pneumatic one in ten
critically ill patients. Cuff pressure was continuously re-
corded for nine hours (three hours with routine care using
a manometer, three hours with continuous control using
an electronic device (Tracoe™) and three hours of continu-
ous control of cuff pressure using a pneumatic device).
The authors found underinflation of Pcuff to be more fre-
quent using the electronic device compared with the
pneumatic device (8% versus 0%, respectively), and attrib-
uted this result to the over compensation for any elevated
cuff pressure.
The impact of pneumatic and electronic devices on con-
tinuous control of cuff pressure is an important issue.
However, only clinical outcomes such as reduction of
microaspiration, VAP, and tracheal ischemia could be used
to justify the extra cost generated from their use. Unfortu-
nately, few clinical studies were performed to determine
the impact of continuous control of cuff pressure on long-
term intubation-related complications.
Our group performed a randomized controlled animal
study to determine the impact of continuous control of
cuff pressure on ischemic tracheal lesions [66]. Piglets
were intubated with a PVC-cuffed tracheal tube, and ven-
tilated for 48 hours under sedation and neuromuscular
blocking agents. They were randomized to receive con-
tinuous control of cuff pressure using a pneumatic device
(n = 6) or routine care using a manometer (n = 6). Overin-
flation of the tracheal cuff was performed in the two
groups in order to mimic overinflation periods in critically
ill patients. Animals were sacrificed after 48 hours of
mechanical ventilation, and the physician who performed
histological examination of the piglets’ trachea was blinded
to study group assignment. Whilst the device was efficient
in continuously controlling cuff pressure, no significant
difference was found in macroscopic or microscopic le-
sions found in study animals. One potential explanation
for the absence of significant effect of continuous control
of cuff pressure on ischemic tracheal lesions is the short
duration of intubation.Two randomized controlled single center clinical studies
evaluated the impact of continuous control of cuff pres-
sure on the incidence of intubation-related complications
[23,70]. Valencia et al. [70] performed a randomized study
in 142 critically ill patients without pneumonia or aspir-
ation at ICU admission. Patients received continuous con-
trol of Pcuff using an electronic artisanal device previously
validated by the same authors (intervention group, n = 73)
or routine care of Pcuff (control group, n = 69). Underinfla-
tion of tracheal cuff was significantly less frequent in inter-
vention compared with control group (45.3% versus 0.7%,
P < 0.001). However, no significant difference was found in
the incidence of microbiologically confirmed VAP be-
tween the two groups (15% in the two groups). Similarly,
no significant difference was found in the incidence of sus-
pected VAP (22% versus 29%), distribution of early and
late-onset VAP, causative microorganisms, ICU (27% versus
23%) or hospital (41% versus 33%) mortality. Some limita-
tions of this study should be taken into account including
single center design, absence of blinding, exclusion of pa-
tients with suspected pneumonia at ICU admission, and ab-
sence of evaluation of microaspiration, colonization, or
tracheal ischemia.
Our group performed a randomized controlled study to
determine the impact of continuous control of cuff pressure
on microaspiration of gastric contents [23]. The secondary
objectives were the impact of this intervention on tracheo-
bronchial colonization, VAP incidence, and ischemic tra-
cheal lesions. Patients requiring mechanical ventilation
through a PVC-cuffed tracheal tube for > 48 hours were eli-
gible, and were randomized to receive continuous control
of cuff pressure using a pneumatic device (intervention
group, n = 61) or routine care (control group, n = 61). Tar-
get cuff pressure was 25 cmH2O in the two groups. Pepsin
was quantitatively measured in all tracheal aspirates during
the 48 hours following randomization. Abundant microas-
piration was defined as the presence of pepsin at significant
level (> 200 ng/mL) in > 65% of tracheal aspirates. Quanti-
tative tracheal aspirate was performed at intubation, and
thrice a week. The pneumatic device was efficient in con-
trolling cuff pressure. Pepsin was measured in 1,205 tra-
cheal aspirates. Percentage of patients with abundant
microaspiration (18% versus 46%, P = 0.002, OR (95% CI)
0.25 (0.11 to 0.59)), bacterial concentration in tracheal aspi-
rates (mean ± SD 1.6 ± 2.4 versus 3.1 ± 3.7 log10 cfu/ml, P =
0.014), and VAP rate (9.8% versus 26.2%, P = 0.032, 0.30
(0.11 to 0.84)) were significantly lower in the intervention
group compared with the control group. Further, percent-
age of days in the ICU with antimicrobials was significantly
lower in the intervention group compared with the control
group (median (Interquartile range) 83 (56, 100) versus 100
(75, 100), P = 0.049. However, no significant difference was
found in tracheal ischemia score (4.5 (1 to 6) versus 4.5
(1 to 7), P = 0.9) between the two groups. Several
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the fact that pepsin was only measured during the 48 hours
following randomization, single center design, absence of
blinding, and important proportion of study patients who
had pneumonia at ICU admission. The absence of signifi-
cant difference in tracheal ischemia score between the two
groups could be explained by the fact that this study was
not powered to detect such an effect. In addition, routine
care was optimal in control group. Further, previous studies
showed that overinflation of the tracheal cuff was not per-
manent and occurred during cough, patient mobilization
and patient-ventilator asynchrony [71]. A previous study
showed that overinflation of the tracheal cuff for up to
30 minutes was associated with significantly reduced but
completely reversible ischemia [29]. Therefore, short over-
inflation of the tracheal cuff might not be harmful in critic-
ally ill patients, and continuous control of Pcuff would not
add much in this scenario. Finally, another explanation
could be the higher Pcuff in patients receiving continuous
control of Pcuff compared with those receiving routine
care, even if the median Pcuff is < 30 cmH2O. A random-
ized controlled animal study found ischemic tracheal le-
sions in animals intubated and ventilated for 48 hours
despite continuous control of Pcuff (< 30 cmH2O) [67].
Further randomized controlled studies are needed to de-
termine the impact of continuous control of Pcuff on ische-
mic tracheal lesions.
Several differences between these two studies might ex-
plain the different results on VAP prevention [72]. Whilst
VAP incidence was the primary outcome in Valencia’s
study, it was a secondary outcome in ours. Patient popula-
tion was also different between the two studies, with more
surgical patients (28% versus 0%), and patients with re-
spiratory disorders (38% versus 27%) in Valencia’s study
than in ours. In addition, the rate of microbiologically con-
firmed VAP was lower in Valencia’s study compared with
ours (15% versus 26%). However, the most important dif-
ference between these studies is probably the different de-
vices used to control Pcuff. Although Valencia et al. used
an electronic device, we used a pneumatic device to con-
tinuously control Pcuff. As discussed previously, the pneu-
matic device is probably more efficient in controlling Pcuff.
Further, the percentage of Pcuff determinations in the nor-
mal range (20 to 30 cmH2O) was lower in Valencia’s study
compared with ours (79% versus 98%).
Conclusions
Microaspiration and ischemic tracheal lesions are com-
mon intubation-related complications. Prevention of
these complications should take into account all patho-
physiologic factors. Cuff pressure should be maintained
between 20 to 30 cmH2O, if possible using a device
allowing continuous control. The polyurethane-cuffed
tracheal tubes could be an interesting measure toprevent microaspiration and pneumonia. Clinical data are
lacking to support the use of the tapered tracheal cuff to
prevent microaspiration in critically ill patient. Further
studies should determine the impact of continuous control
of cuff pressure on the incidence of intubation-related
complications, and evaluate the impact of cuff material
and shape on microaspiration and VAP.
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